Skip to content

Clinical trials

Enrolling by invitation Neurodegenerative Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Status: Enrolling by invitation Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20171
20211
20235
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Texas at Austin2
Beijing Tiantan Hospital1
BlueRock Therapeutics1
Chinese University of Hong Kong1
Duke University1
Fondazione Don Carlo Gnocchi ETS1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
IRCCS San Raffaele1
KU Leuven1
MapLight Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases16
Alzheimer Disease6
Parkinson Disease6
Nervous System Diseases5
Brain Diseases4
Aphasia, Primary Progressive3
Central Nervous System Diseases3
Cognitive Dysfunction3
Dementia3
Movement Disorders3

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.